IRCT20171018036870N2已完成2 期
Combined metformin and sitagliptin effect on expression levels of proteins involved in insulin resistance (IRS-1/PI3K/Akt/mTOR/GLUT4) in adipose tissue of diabetic patients
Yazd University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes who have not yet taken medication and are recently diagnosed with a blood glucose test, the so-called New Case.
排除标准
- •Diabetics who are taking medications, taking pills or taking insulin, have been eliminated.
研究者
相似试验
招募中
不适用
Effects of Metformin, Sitagliptin and Empagliflozin as the first therapy for patients with type 2 diabetes: a randomized controlled study: MOSEL-first studyType2 diabetesJPRN-UMIN000035791Yokohama City University Medical Center99
招募中
3 期
Synchronization of metformin with sitagliptin on the expression of` miRNA21, 223 in insulin resistant human adipocyte tissue and serumInsulin resistance.IRCT20180408039225N1Yazd University of Medical Sciences30
已完成
3 期
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)Type 2 Diabetes MellitusNCT02532855Merck Sharp & Dohme LLC614
已完成
2 期
Effect of metformin on the expression of non-coding long-term RNA in diabetic patients.Diabetes mellitus type II in people New case.Diabetes mellitus due to underlying conditionIRCT20190303042903N1Yasouj University of Medical Sciences35
进行中（未招募）
1 期
Efficacy of Metformin versus sitagliptin on benign thyroid nodules in type 2 diabetesEUCTR2019-000676-42-FRniversity Center Hospital of Guadeloupe90